{
    "root": "034bf68c-288b-4943-8ce7-045afa12b4ec",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "OZURDEX",
    "value": "20250520",
    "ingredients": [
        {
            "name": "DEXAMETHASONE",
            "code": "7S5I7G3JQL"
        }
    ],
    "indications": "OZURDEX ® is a corticosteroid indicated for: The treatment of macular edema following branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO) ( 1.1 ) The treatment of non-infectious uveitis affecting the posterior segment of the eye ( 1.2 ) The treatment of diabetic macular edema ( 1.3 )",
    "contraindications": "For ophthalmic intravitreal injection. ( 2.1 ) The intravitreal injection procedure should be carried out under controlled aseptic conditions. ( 2.2 ) Following the intravitreal injection, patients should be monitored for elevation in intraocular pressure and for endophthalmitis. ( 2.2 )",
    "warningsAndPrecautions": "OZURDEX\n                     \n                        ®\n                     \n                      (dexamethasone intravitreal implant) 0.7 mg is supplied in a foil pouch with 1 single-use plastic applicator, NDC 0023-3348-07.\n                  \n                     Storage: Store at 15oC to 30oC (59oF to 86oF).",
    "adverseReactions": "Ocular or periocular infections ( 4.1 ) Glaucoma ( 4.2 ) Torn or ruptured posterior lens capsule ( 4.3 ) Hypersensitivity ( 4.4 )"
}